Results - Announcements
IOL Chemicals & Pharmaceuticals Ltd share price softened by 3.84% to Rs 177.75. The Company's net profit grew slightly 1.04% to Rs 65.07 crore, while revenue from operations slightly gained 5.13% to Rs 795.03 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.48%. It has marginally improved by 6.57% over last one week and ticked higher by 1.39% in last one month while the market capitalization of IOL Chemicals & Pharmaceuticals Ltd has improved by 8.78% and 21.58% in the same period respectively.
Profit before tax (PBT) of IOL Chemicals & Pharmaceuticals Ltd stood at Rs 87.29 crore in Q3 FY26, surging by 115.58% year-on-year, and easing 0.69% quarter-on-quarter. EBITDA came in at Rs 104 crore, rallying 106.99% YoY and rising 9.02% sequentially.
Total expenses posted a minor rise of 5% to Rs 707.81 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 505.31 crore, marginally falling by 0.29% YoY, while employee benefits expense was at Rs 68.71 crore, softening 3.51% YoY.
For the TTM ended FY26, revenue from operations advanced 11.54% to Rs 2319.06 crore, while net profit jumped 36.18% to Rs 137.64 crore, compared to previous TTM. EBITDA surged by 18713% to Rs 247.59 crore, and PBT surged 33.63% to Rs 184.36 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 214.32 crore in FY26, as against Rs 178.62 crore in FY25.
IOL Chemicals & Pharmaceuticals Ltd rallied 90.41% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 11.78% during the same period.